Literature DB >> 16484630

PPARs: a new target for neuroprotection.

R Bordet, P Gelé, P Duriez, J-C Fruchart.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16484630      PMCID： PMC2077704          DOI： 10.1136/jnnp.2005.077495

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  30 in total

1.  Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS.

Authors:  S Moreno; S Farioli-Vecchioli; M P Cerù
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

Review 2.  Therapeutic potential of peroxisome proliferator-activated receptor agonists for neurological disease.

Authors:  Douglas L Feinstein
Journal:  Diabetes Technol Ther       Date:  2003       Impact factor: 6.118

Review 3.  Oxidative stress in neurodegeneration: cause or consequence?

Authors:  Julie K Andersen
Journal:  Nat Med       Date:  2004-07       Impact factor: 53.440

4.  Distribution of mRNAs encoding the peroxisome proliferator-activated receptor alpha, beta, and gamma and the retinoid X receptor alpha, beta, and gamma in rat central nervous system.

Authors:  T E Cullingford; K Bhakoo; S Peuchen; C T Dolphin; R Patel; J B Clark
Journal:  J Neurochem       Date:  1998-04       Impact factor: 5.372

5.  Anti-inflammatory and antiproliferative actions of PPAR-gamma agonists on T lymphocytes derived from MS patients.

Authors:  Stephan Schmidt; Edin Moric; Martina Schmidt; Magdalena Sastre; Douglas L Feinstein; Michael T Heneka
Journal:  J Leukoc Biol       Date:  2003-12-04       Impact factor: 4.962

6.  Peroxisome proliferator-activated receptor alpha agonists as therapy for autoimmune disease.

Authors:  Amy E Lovett-Racke; Rehana Z Hussain; Sara Northrop; Judy Choy; Anne Rocchini; Lela Matthes; Janet A Chavis; Asim Diab; Paul D Drew; Michael K Racke
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

Review 7.  Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation.

Authors:  Christophe Blanquart; Olivier Barbier; Jean Charles Fruchart; Bart Staels; Corine Glineur
Journal:  J Steroid Biochem Mol Biol       Date:  2003-06       Impact factor: 4.292

8.  Localization of PPARdelta in murine central nervous system: expression in oligodendrocytes and neurons.

Authors:  John W Woods; Michael Tanen; David J Figueroa; Chhabi Biswas; Emanuel Zycband; David E Moller; Christopher P Austin; Joel P Berger
Journal:  Brain Res       Date:  2003-06-13       Impact factor: 3.252

9.  Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation.

Authors:  Thomas Dehmer; Michael T Heneka; Magdalena Sastre; Johannes Dichgans; Jörg B Schulz
Journal:  J Neurochem       Date:  2004-01       Impact factor: 5.372

Review 10.  Insulin and neurodegenerative disease: shared and specific mechanisms.

Authors:  Suzanne Craft; G Stennis Watson
Journal:  Lancet Neurol       Date:  2004-03       Impact factor: 44.182
View more
  11 in total

1.  Endocannabinoid-Binding Receptors as Drug Targets.

Authors:  María Gómez-Cañas; Carmen Rodríguez-Cueto; Valentina Satta; Inés Hernández-Fisac; Elisa Navarro; Javier Fernández-Ruiz
Journal:  Methods Mol Biol       Date:  2023

Review 2.  Epigenetic regulation of astrocyte function in neuroinflammation and neurodegeneration.

Authors:  Matthew Neal; Jason R Richardson
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-11-04       Impact factor: 5.187

Review 3.  PPARγ/PGC1α signaling as a potential therapeutic target for mitochondrial biogenesis in neurodegenerative disorders.

Authors:  Sumit Jamwal; Jennifer K Blackburn; John D Elsworth
Journal:  Pharmacol Ther       Date:  2020-10-09       Impact factor: 12.310

4.  Peroxisome proliferator-activated receptors α and γ are linked with alcohol consumption in mice and withdrawal and dependence in humans.

Authors:  Yuri A Blednov; Jillian M Benavidez; Mendy Black; Laura B Ferguson; Grant L Schoenhard; Alison M Goate; Howard J Edenberg; Leah Wetherill; Victor Hesselbrock; Tatiana Foroud; R Adron Harris
Journal:  Alcohol Clin Exp Res       Date:  2014-12-16       Impact factor: 3.928

5.  New insights into the role of peroxisome proliferator-activated receptors in regulating the inflammatory response after tissue injury.

Authors:  Miriam D Neher; Sebastian Weckbach; Markus S Huber-Lang; Philip F Stahel
Journal:  PPAR Res       Date:  2012-02-29       Impact factor: 4.964

Review 6.  Relevance of Peroxisome Proliferator Activated Receptors in Multitarget Paradigm Associated with the Endocannabinoid System.

Authors:  Ana Lago-Fernandez; Sara Zarzo-Arias; Nadine Jagerovic; Paula Morales
Journal:  Int J Mol Sci       Date:  2021-01-20       Impact factor: 5.923

7.  The Expanded Endocannabinoid System Contributes to Metabolic and Body Mass Shifts in First-Episode Schizophrenia: A 5-Year Follow-Up Study.

Authors:  Madis Parksepp; Liina Haring; Kalle Kilk; Kadri Koch; Kärt Uppin; Raul Kangro; Mihkel Zilmer; Eero Vasar
Journal:  Biomedicines       Date:  2022-01-24

8.  Expression Pattern of Peroxisome Proliferator-Activated Receptors in Rat Hippocampus following Cerebral Ischemia and Reperfusion Injury.

Authors:  Hong Wang; Rong Jiang; Qin He; Yunmei Zhang; Yanli Zhang; Yong Li; Ruichun Zhuang; Ying Luo; Yu Li; Jinyuan Wan; Yong Tang; Huarong Yu; Qingsong Jiang; Junqing Yang
Journal:  PPAR Res       Date:  2012-12-09       Impact factor: 4.964

9.  Peroxisome proliferator-activated receptors: "key" regulators of neuroinflammation after traumatic brain injury.

Authors:  Philip F Stahel; Wade R Smith; Jay Bruchis; Craig H Rabb
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

10.  Peroxisome proliferator-activated receptor and age-related macular degeneration.

Authors:  Alexandra A Herzlich; Jingsheng Tuo; Chi-Chao Chan
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.